Join Our Mailing List

What We Do
Preventive Program
Adult Education and Literacy
Youth Program
Legal Services Program
Health Program
Anti-Violence Program
Khalil Gibran International Academy
I Need To Be Heard!

Program Contact Information

Danny Salim
Anti-Violence Program Manager
(718) 250 - 5122


By K. Bernado. Missouri Tech. 2018.

Presentation sample was hemodilute with no definite LAIP (other markers not shown) discount zestoretic 17.5 mg mastercard. Postcourse 1 sample had a small number of cells in an empty space (CD34 HLADRlow generic zestoretic 17.5 mg with visa, in blue) but categorized as insufficient to define as MRD without a diagnostic LAIP; however generic 17.5 mg zestoretic otc, the postcourse 2 sample had obvious MRD within the same empty space buy 17.5mg zestoretic with mastercard. Change in leukemic immunophenotype with MRD postcourse 3 from an emerging new aberrant subpopulation in an empty space (CD33 CD13low purchase 17.5mg zestoretic with visa, in blue). This patient relapsed with the same aberrant phenotype but the diagnostic LAIPs were not present (including from other markers not shown). There are also different approaches to defining MRD positivity/negativity, either by using cutoff values Standardization of MFC-MRD derived from combined data of multiple phenotypic aberrancies at Despite the powerful prognostic value of MFC-MRD, standardiza- postinduction/consolidation time points or by defining MRD positiv- tion and therefore comparability of results between laboratories ity as any level of MRD detectable above the relevant aberrant combination sensitivity threshold. Although MFC-MRD can be applied to most AML patients, this involves multiple aberrant antigen combinations first approach tested different MFC-MRD cutoff values by relapse detected by evolving antibody panels developed separately by probability and showed significant differences in relapse for MFC- laboratories. This is analogous to standardizing quantitative polymer- MRD detected above 0. The cutoff value was similar whether or not the MFC-MRD laboratories using different primers for each target. There is value incorporated a correction for LAIP frequency in the presenta- variation in the quantitation of MFC-MRD (ie, % of total nucleated tion sample and was not improved by using log reduction values. Proportion of AML patients informative for MRD detection by RT-qPCR for leukemia-specific MRD targets (ie, fusion genes, NPM1 mutation) according to age. Integration of flow cytometric and genetic different variable primers to cover the common isoform types data will allow optimization of predictive cutoffs for specific LAIPs encountered in primary patient samples. Specific probes (rather than when these are associated with different genetic abnormalities—for SYBR green I) were used to detect target amplicons to enhance example, aberrant CD7 in AML with CEBPA or FLT3-ITD assay sensitivity and specificity. Incorporation of a correction factor for hemodilution34 is protocols that included reaction conditions for all steps of the another consideration for standardized reporting as well as reduc- RT-qPCR procedure, a key achievement of the EAC program was tion of false negatives. This process identified ABL as the most reliable control between pediatric and adult AML for the specificity and frequency 40 gene. Although some laboratories prefer to use alternative house- of aberrancies. Improved selection and analysis of leukemic aberran- keeping genes, there is no evidence that these are superior; cies could be achieved by Web-based access to international therefore, consistent use of ABL for assay normalization would interlaboratory shared resources of the most useful robust LAIPs/ greatly facilitate comparison of MRD data between laboratories. Data from samples, together in triplicate wells, provided guidance concerning acceptable sample with control BM processed by standardized flow cytometric proto- quality indicated by the level of housekeeping gene expression and cols in different laboratories, could be analyzed remotely, thereby accessing a core facility of appropriate expertise. It is feasible that established clear criteria used to define PCR positivity (ie, specific further development of automated analysis algorithms combined amplification in the MRD assay in at least 2 of 3 replicate wells with with high-dimensional cytometry applied as a different-from- average cycle threshold value 40). Although some laboratories still use conventional RT-PCR with nested primers for MRD detection, this approach has a number of Real-time quantitative PCR limitations and should be abandoned in favor of RT-qPCR, The development of these assays in the 1990s provided a major step which is more reliable and readily standardized. Performance of forward in establishing standardized approaches for MRD detection the same RT-qPCR platform is highly reproducible between in a range of leukemias. In AML, they can be applied in cases with laboratories, turnaround time is more rapid, and risk of PCR chimeric fusion genes generated by balanced chromosomal rearrange- contamination is substantially reduced. A further key advantage ments—for example, PML-RARA/t(15;17), RUNX1-RUNX1T1/t(8; of RT-qPCR is the capacity to quantify an independent housekeep- 21), CBFB-MYH11/(inv(16)/t(16;16), DEK-CAN(NUP214)/t(6;9), ing gene in parallel, enabling suboptimal follow-up samples that t(11q23)/MLL fusions, t(5;11)/NUP98-NSD1 or NPM1 mutations, collectively covering 60% of AML presenting in children and could potentially have given rise to false-negative PCR results to younger adults (Figure 3). Importantly, qualitative end- generate complementary DNA before the quantitative PCR (qPCR) point assays lack the capacity to measure the absolute level of step. This allows a relatively limited panel of optimized standard- leukemic transcripts or determine whether they are rising or ized assays to be used, circumventing the need to characterize falling, which is invaluable information for clinical decision- translocation breakpoints at the genomic level, which can be making. The EAC program laid the groundwork for defining challenging and not realistic in routine laboratories. Use of MRD monitoring to inform clinical prognostic information. The standardized EAC level after 2 courses of chemotherapy being at significantly in- PML-RARA RT-qPCR assay has been shown to improve MRD creased risk of subsequent relapse. Therefore, marrow is toring using the standardized EAC assays as a tool to distinguish the recommended sample source for serial MRD monitoring where more precisely those CBF leukemia patients destined to relapse the goal is to detect recurrent disease promptly—allowing a from those who can be cured with chemotherapy alone. Clinically sufficient window of time to confirm PCR positivity in an indepen- relevant threshold transcript levels were defined, with studies dent sample and to initiate preemptive therapy to prevent progres- consistently showing that relapse can be predicted by persistently sion to frank relapse with its associated risk of fatal bleeding. MRD monitoring to guide early intervention has been shown to reduce the risk of induction of hyperleukocytosis and the associated NPM1 mutant AML. Frameshift mutations in exon 12 of the differentiation syndrome as compared with treatment in the context NPM1 gene are found in approximately one-third of AML cases, of frank relapse. Mutation-specific prim- been recommended in the National Comprehensive Cancer Network ers can be readily designed to allow MRD detection in AML guidelines to inform treatment approach. The NPM1 mutant transcript is typically highly treated in clinical trials, particularly those including ATO as expressed in diagnostic AML samples, affording sensitivities typi- frontline therapy, the value of routine sequential monitoring for cally higher (median 1 in 105) than observed with RT-qPCR assays PML-RARA transcripts beyond the postconsolidation time point has for other molecular subtypes of AML, with RNA-based assays been increasingly questioned.

zestoretic 17.5 mg on-line

Dorkhan M zestoretic 17.5mg free shipping, Magnusson M discount zestoretic 17.5mg with amex, Frid A 17.5mg zestoretic otc, Grubb A 17.5 mg zestoretic for sale, Groop L buy 17.5 mg zestoretic with mastercard, Jovinge S. Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes. Relationship between plasma hANP level and pretibial edema by pioglitazone treatment. Kawamori R, Kadowaki T, Onji M, Seino Y, Akanuma Y, Group PS. Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: postmarketing surveillance study in Japan. The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment. Two-year effect of rosiglitazone in chinese poorly controlled type 2 diabetic patients. Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels. Panikar V, Joshi SR, Bukkawar A, Nasikkar N, Santwana C. Induction of long-term glycemic control in type 2 diabetic patients using pioglitazone and metformin combination. The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials. Rosak C, Petzoldt R, Wolf R, Reblin T, Dehmel B, Seidel D. Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large Thiazolidinediones Page 106 of 193 Final Report Update 1 Drug Effectiveness Review Project observational studies in people with type 2 diabetes. Rosiglitazone is effective and well- tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes. Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight. The long-term effects of rosiglitazone on serum lipid concentrations and body weight. Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial. A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea. Vongthavaravat V, Wajchenberg BL, Waitman JN, et al. An international study of the effects of rosiglitazone plus sulphonylurea in patients with type 2 diabetes. Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus. Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A, PROactive Study Group. The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: Results from a controlled randomized study. Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study. Matthews DR, Charbonnel BH, Hanefeld M, Brunetti P, Schernthaner G. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study. Thiazolidinediones Page 107 of 193 Final Report Update 1 Drug Effectiveness Review Project 232. A case of secondary diabetes mellitus with acromegaly improved by pioglitazone. Rosiglitazone in the management of older patients with type 2 diabetes mellitus.

generic zestoretic 17.5 mg mastercard

The different clinical pharmacology of elvucitabine (beta-L-Fd4C) enables the drug to be given in a safe and effective manner with innovative drug dosing order 17.5 mg zestoretic. Multiple-dose pharmacokinetic behavior of elvucitabine 17.5 mg zestoretic overnight delivery, a nucleoside reverse transcriptase inhibitor buy discount zestoretic 17.5mg on line, administered over 21 days with lopinavir-ritonavir in human immunodeficiency virus type 1-infected subjects buy cheap zestoretic 17.5 mg on-line. Stampidine is a potential nonspermicidal broad-spectrum anti-HIV microbicide discount zestoretic 17.5mg overnight delivery. Elvucitabine phase II 48 week interim results show safety and effi- cacy profiles similar to lamivudine in treatment naive HIV-1 infected patients with a unique pharmacokinetic profile. Elvucitabine vs lamivudine with tenofovir and efavirenz in anti- retroviral-treatment-naïve HIV-1 infected patients: 96 week final results. ART 2017/2018: The horizon and beyond 123 Dunkle LM, Gathe JC, Pedevillano DE, et al. Elvucitabine: potent antiviral activity demonstrated in multidrug- resistant HIV infection. In vitro induction of HIV variants with reduced susceptibility to elvucitabine (ACH-126,443,beta-L-Fd4C). In vitro investigation of the resistance profile of apricitabine. Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infec- tion. Ann Pharmacother 2009, 43:1676-83 Girard PM, Pegram PS, Diquet B, et al. Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy. In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infec- tion. Harris KS, Brabant W, Styrchak S, Gall A, Daifuku R. KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Safety, pharmacokinetics, and efficacy of (+/-)-beta-2’,3’-dideoxy-5- fluoro-3’-thiacytidine with efavirenz and stavudine in antiretroviral-naive HIV-infected patients. Hurwitz SJ, Asif G, Fromentin E, Tharnish PM, Schinazi RF. Lack of pharmacokinetic interaction between amdox- ovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals. Comparative pharmacokinetics of Racivir, (+/-)-beta-2’,3’-dideoxy-5-fluoro-3’- thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans. Kravtchenko AV, Salamov GG, Serebrovskaya LV, et al. The first experience of HAART with phosphazid + didano- sine + nevirapine in HIV-infected patients in Russia. Abstract 3, 5th Int Conf Drug Therapy 2000, Glasgow, Scotland. Phosphoramidate and phosphate prodrugs of (-)-beta-d-(2R,4R)- dioxolane-thymine: Synthesis, anti-HIV activity and stability studies. Safety profile of SPD754 in cynomolgus monkeys treated for 52 weeks, Abstract 527, 11th CROI 2004, San Francisco. Antiviral activity and resistance profile of phosphazid – a novel prodrug of AZT. Phase I/II study of the pharmacokinetics, safety and antiretroviral activ- ity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults. Mechanism of inhibition of HIV-1 reverse transcriptase by 4’- Ethynyl-2-fluoro-2’-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. J Biol Chem 2009, 284:35681-91 Mills A, Crofoot G Jr, McDonald C, et al. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study. Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC- TP.

generic 17.5mg zestoretic

However discount 17.5mg zestoretic free shipping, the time-consuming shak- bigger generic 17.5mg zestoretic with amex, relatively painless and have a smooth buy 17.5 mg zestoretic otc, in- ing procedure and difficulties in interpretation durated border and a smooth base (Figure 6b) buy zestoretic 17.5mg fast delivery. These signs of primary syphilis are seen specific serological test (rapid tests) has been on about 2–10 weeks after infection purchase 17.5 mg zestoretic with amex. The second- the market for a few years and provides a good ary stage of syphilis develops 1–3 months after alternative for settings where RPR testing has the primary stage. They appear as a macular– met difficulties19,20 and is now recommended papular rash and/or moist papules (condylomata as a screening test18. After this secondary stage, the infection treponemal test which is very easy to use, can be enters a latent phase without any signs and used with full blood, serum or plasma and can be symptoms that can last for years. The disadvantage stage is characterized by granulomas of the skin, is, as with other treponemal tests, that the test 190 Sexually Transmitted Infections and Reproductive Tract Infections cannot distinguish between active and previ- ously treated infection. It should be confirmed by RPR (non-treponemal test). WHO recom- mends the introduction of the treponemal rapid test only in places where the RPR test has not yet been introduced or poses difficulties because of the demand for a fridge and the use of serum. Syphilis screening using the RPR is recommended dur- ing antenatal care. Congenital syphilis Syphilis prevalence in pregnant women in sub-Saharan Africa still exceeds 5% in some countries. In women with untreated early syphilis, 25% of pregnancies may end in abortion or in stillbirths and 14% in neonatal deaths1,15,20. In addition about one-third of infants of infected mothers are born with congenital syphilis (Figure 7). Syphilis screening and treatment has shown to reduce stillbirth by 80%21. Late signs of secondary congenital syphilis are teeth deformities, deformities of the skeletal sys- tem and deafness. Congenital syphilis can be prevented by screening and treatment of the mother during pregnancy. Syphilis screening has been promoted as an essential element of antenatal care for many years and is a very cost-effective public health measure. In recent years, a new, very simple rapid Table 5 Interpretation of serological tests for syphilis if the new rapid test is used as first choice screening test Treponemal test Non-treponemal test (rapid test) (RPR, VDRL) Likely interpretation + + Syphilis – + False-positive RPR (no syphilis) + – Primary or latent syphilis, previously treated syphilis – – No syphilis RPR, rapid plasma regain; VDRL, Venereal Disease Figure 7 Congenital syphilis. US Centers for Disease Control and Prevention 191 GYNECOLOGY FOR LESS-RESOURCED LOCATIONS point-of-care treponemal test has been made undiagnosed. Two to three weeks later confluent available which presents a cost-effective, easy-to- inguinal nodes develop and might show multiple perform alternative for screening for syphilis in fistulae. These inguinal bubo are often multiple pregnant mothers where RPR is not available22. However, diagnosis is more days or procaine benzylpenicillin 50,000 mostly done on the basis of clinical appearance. Children born to a syphilis- Granuloma inguinale Granuloma inguinale is a rare positive mother should receive 50,000 units/kg STI and is only endemic in a few countries, out of of body weight, intramuscularly, in a single dose. The ulcers are often vesicular lesions the Caribbean). The infection is also called dono- and look like tiny blisters. Note: aciclovir may not within histiocytes in Giemsa, Leishman or be available in many countries or only in clinics Wright’s stained tissue smear. An alternative is specialized for treatment of opportunistic infec- the histological examination for Donovan bodies tions of HIV. In this case the patient has to wait using Giemsa or silver stain. Amplification for spontaneous remission which normally methods are not commercially available. Patients should be Genital wart and condylomata acuminata Genital warts advised to abstain from sexual intercourse or to and condylomata acuminata are caused by HPV use condoms. These two subtypes are so-called Chancroid The ulcers of chancroid (caused by Haemo- low-risk HPV subtypes as they have little or no risk philus ducreyi) have irregular margins, are deep, have of causing cancerous disease as opposed to subtypes undetermined edges, are extremely painful and are 16 and 18 which cause cervical cancer but not gen- accompanied by tender inguinal lymphadenopathy ital warts. Appearance differs from flat papular warts (inguinal bubo) in 70% of cases (Figure 6). Condyloma acuminata • Laboratory: culture on specific media, DNA may remain unchanged or spontaneously resolve, amplification.

9 of 10 - Review by K. Bernado
Votes: 346 votes
Total customer reviews: 346


The Arab-American Family Support Center is a 501(c)3 non-profit, non-sectarian organization that provides culturally and linguistically sensitive services to immigrant communities throughout New York City.  © 2017 All Rights Reserved.

AAFSC Brooklyn
150 Court Street, 3rd Flr
Brooklyn, NY 11201
T: 718 - 643 - 8000
F: 718 - 797 - 0410
E: info@aafscny.org
AAFSC Queens
37-10 30th Street, 2nd Fl.

Queens, NY 11101
T: 718 - 937 - 8000
F: 347 - 808 - 8778
AAFSC @ the Family Justice Centers
FJC Bronx (718) 508-1220
FJC Brooklyn (718) 250 - 5035
FJC Manhattan (212) 602-2800
FJC Queens (718) 575 - 4500
FJC Staten Island (718) 697 - 4300